ORIC - ORIC Pharmaceuticals GAAP EPS of -$0.37 beats by $0.07
2024-05-06 17:32:46 ET
More on ORIC Pharmaceuticals
- ORIC Pharmaceuticals: Rally Seems Overdone
- ORIC Pharmaceuticals: Mid-2024 Prostate Cancer Program Update Could Lead To Gains
- ORIC Pharmaceuticals GAAP EPS of -$0.49
- Cantor starts ORIC at overweight, cites potential of ORIC-114
- Seeking Alpha’s Quant Rating on ORIC Pharmaceuticals